Get started
Work

Supplementary Table 2 from Phase II Study of Bevacizumab in Combination with Sorafenib in Recurrent Glioblastoma (N0776): A North Central Cancer Treatment Group Trial

Year: 2023
Type: supplementary-materials
Abstract: Supplementary Table 2 - PDF file 54K, SNPs Analyzed and Genotype Frequencies
DOI: 10.1158/1078-0432.22445372.v1
Authors: Evanthia Galanis, S. Keith Anderson, Jackie M. Lafky, Joon H. Uhm, Caterina Giannini, Shaji K. Kumar, Teresa K. Kimlinger, Donald W. Northfelt, Patrick J. Flynn, Kurt A. Jaeckle, Timothy J. Kaufmann, Jan C. Buckner
Language: English
Subfield: Genetics
Field: Medicine
Open Access status: gold
OpenAlex ID: W4361902972
Cites:
Cited by:
Related to: 10